Cargando…
Prolyl Oligopeptidase Inhibition Attenuates Steatosis in the L02 Human Liver Cell Line
BACKGROUND: Prolyl oligopeptidase (POP) is a serine endopeptidase that is widely distributed in vivo, particularly in the liver. Significant changes in functional mitochondrial proteins involved with mitochondrial oxidoreductases/transporters and nucleic acid binding proteins were observed after POP...
Autores principales: | Zhou, Da, Li, Bing-Hang, Wang, Jing, Ding, Yong-Nian, Dong, Yan, Chen, Yuan-Wen, Fan, Jian-Gao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070736/ https://www.ncbi.nlm.nih.gov/pubmed/27760195 http://dx.doi.org/10.1371/journal.pone.0165224 |
Ejemplares similares
-
Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
por: Tenorio-Laranga, Jofre, et al.
Publicado: (2010) -
The role of prolyl oligopeptidase, understanding the puzzle
por: García-Horsman, J. Arturo
Publicado: (2020) -
Inhibition of Prolyl Oligopeptidase Prevents Consequences of Reperfusion following Intestinal Ischemia
por: Filippone, Alessia, et al.
Publicado: (2021) -
Prolyl Oligopeptidase, Inositol Phosphate Signalling and Lithium Sensitivity
por: Harwood, Adrian J
Publicado: (2011) -
Prolyl oligopeptidase inhibition ameliorates experimental pulmonary fibrosis both in vivo and in vitro
por: Cucinotta, Laura, et al.
Publicado: (2023)